The American Association of Oral and Maxillofacial Surgeons provided new guidance for treating medication-related osteonecrosis of the jaw.
The recommendations prioritize prevention while continuing necessary cancer treatment to maintain quality of life and support bone health, according to an Oct. 18 news release. Strategies include maintaining oral hygiene, performing high-risk surgical procedures before initiating drug therapies, quitting smoking and optimizing diabetes care. The recommendations also minimize the role of medications other than antiresorptives in causing the condition.
The group noted that a multidisciplinary approach is needed, with healthcare providers recognizing the importance of coordinated dental care and treatment planning.